Skip to content
Stop using now Drug recall · FDA · Published February 10, 2014

Hospira Bupivacaine Vial Recall: Visible Particulate Matter Hazard

Hospira recalls 30mL bupivacaine vials with visible particulate matter. Affected vials may cause serious injury if injected. Stop using immediately and contact Hospira for details.

🇺🇸 FDA recall #D-1147-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira is recalling bupivacaine injection vials that contain visible particles. Using these vials could cause serious injury if the particles enter the bloodstream during injection. Read more at govinfonow.com/recall/46265-hospira-bupivacaine-vial-recall-visible-particulate-matter-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/46265-hospira-bupivacaine-vial-recall-visible-particulate-matter-hazard · Updated August 20, 2026 · FDA enforcement record: FDA #D-1147-2014

Cite this page

“Hospira Bupivacaine Vial Recall: Visible Particulate Matter Hazard.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/46265-hospira-bupivacaine-vial-recall-visible-particulate-matter-hazard. Based on FDA recall #D-1147-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1147-2014%22&limit=1).

The FDA announced on Feb. 10, 2014, that Hospira Inc. voluntarily recalled Bupivacaine HCl Inj. USP vials due to the presence of particulate matter. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Hospira
  • Product: Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial
  • NDC: 0409-1162-02
  • Lot: 25-097-DK
  • Expiration: 01/01/2015

The hazard

The recall addresses confirmed customer reports of visible particulate embedded in the glass vial. The FDA classified the issue as a Class II recall.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (July 24, 2026), Apollo Care SEMAGLUTIDE 5mg Vial Recall (July 29, 2026), and GE Healthcare Omnipaque 300 mg/mL Injection Recall (March 24, 2026).

How to tell if you have this one

Check for vials with the label 'Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only'. The lot number is 25-097-DK and expiration date is January 1, 2015.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    Discard the vial if you have it and contact Hospira for instructions.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3 years after the firm started it.

1. Firm started the recall: Feb 10, 201412. FDA classified it Class II: Mar 5, 201423. Published in FDA’s Enforcement Report: Mar 12, 201434. FDA terminated the recall: Feb 1, 2017420142017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1147-2014 (February 10, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1147-2014 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA